Virax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle East

Group 1 - Virax Biolabs Group Limited has entered into a distribution agreement to commercialize RT PCR Mpox virus detection kits in 13 European countries and GCC nations [1][3] - The RT PCR Mpox virus detection kits are CE-marked for sale in Europe and authorized by the UK's Medicines and Healthcare products Regulatory Agency, with a sensitivity of 96.7% and specificity of 93.72%, delivering results in under 70 minutes [2] - The partnership aims to equip healthcare professionals with tools to diagnose and mitigate the spread of the Mpox virus, reaching at-risk communities across major geographies [3] Group 2 - Virax Biolabs is focused on the detection of immune responses and diagnosis of viral diseases, currently developing T-Cell-based test technologies for immunology profiling [5]